ResMed profits up in pandemic
Sleep disorder company ResMed has announced rising profits and revenues during a pandemic year where its ventilators were called upon to treat Covid-19 sufferers. The US-Australian company announced a 12 per cent rise in operating profit for the year to June 30, on revenues up eight per cent to $4.3 billion (US$3.2 billion). The final…
Details